Survival Benefit of Long-Term Sorafenib Treatment in Patients with Advanced Hepatocellular Carcinoma in Indonesia: Multicenter experience

被引：0
|
作者：
Lesmana, Cosmas R. [1 ,2 ]
Gani, Rino A. [1 ]
Pakasi, Levina S. [2 ]
Hasan, Irsan [1 ]
Waspodo, Agus S. [3 ]
Siregar, Lianda [3 ]
Budi, Poernomo [4 ]
Lesmana, Laurentius A. [1 ,2 ]
机构：
[1] Cipto Mangunkusumo Hosp, Jakarta, Indonesia
[2] Medistra Hosp, Digest Dis & GI Oncol Ctr, Jakarta, Indonesia
[3] Dharmais Canc Ctr Hosp, Jakarta, Indonesia
[4] Dr Soetomo Hosp, Surabaya, Indonesia
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1389
引用
收藏
页码：866A / 867A
页数：2
相关论文
共 50 条
  • [1] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [2] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [3] Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study
    Sacco, Rodolfo
    Granito, Alessandro
    Bargellini, Irene
    Zolfino, Teresa
    Saitta, Carlo
    Marzi, Luca
    Tapete, Gherardo
    Bresci, Giampaolo
    Marinelli, Sara
    Tovoli, Francesco
    Attardo, Simona
    Rossi, Margherita
    Urbani, Lucio
    Marchi, Santino
    Buccianti, Piero
    Cabibbo, Giuseppe
    FUTURE ONCOLOGY, 2018, 14 (29) : 3049 - 3058
  • [4] Pancreatic Atrophy in Hepatocellular Carcinoma Patients Receiving Long-Term Treatment with Sorafenib
    Ganten, Maria-Katharina
    Schuessler, Max
    Bruckner, Thomas
    Ganten, Tom M.
    Koschny, Ronald
    ONCOLOGY, 2015, 89 (02) : 88 - 94
  • [5] Sorafenib's survival benefit and comparison with other treatment modalities in advanced hepatocellular carcinoma
    Khatri, P. K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Trans-arterial chemoembolization with sorafenib treatment improves long-term overall survival of patients with intermediate hepatocellular carcinoma
    Yao, Zhen
    Hao, Weiyuan
    Guo, Liwen
    Zeng, Hui
    Chen, Yutang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10569 - 10578
  • [7] Long-term survival outcomes of atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma.
    Chen, Ching-Tso
    Feng, Yin-Hsun
    Yen, Chia-Jui
    Chen, San-Chi
    Hsu, Chih-Hung
    Shao, Yu-Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [8] Early Experience of Combination Treatment of Sorafenib and Radiotherapy in Advanced Hepatocellular Carcinoma Patients
    Cha, J.
    Seong, J.
    Han, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S306 - S307
  • [9] LONG-TERM ADMINISTRATION OF SORAFENIB AND INITIAL DOSAGE PER BODY WEIGHT ARE ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH UNRESECTABLE ADVANCED HEPATOCELLULAR CARCINOMA
    Hiramine, Yasunari
    Uto, Hirofumi
    Imamura, Yasushi
    Tabu, Kazuaki
    Toyokura, Eriko
    Hiwaki, Takuya
    Sho, Yukihiko
    Baba, Yoshirou
    Tahara, Kenji
    Higashi, Hirohumi
    Tamai, Tsutomu
    Oketani, Makoto
    Ido, Akio
    Tsubouchi, Hirohito
    HEPATOLOGY, 2011, 54 : 1379A - 1380A
  • [10] Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study
    Marasco, G.
    Colecchia, A.
    Reggiani, M. L. Bacchi
    Dajiti, E.
    Ravaioli, F.
    Avanzato, F.
    Trevisani, F.
    Festi, D.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E50 - E50
12345